Aardvark Therapeutics, Inc.
Last 30 daysNo qualifying insider buying. Sales: $394.96K by 1 insider.
Director
Stock Option (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Option (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Option (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock Option (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| Director | Stock Option (right to buy)Grant or award | Derivative units44,964Award · no purchase price | Non-cash award | Aug 14Filed Aug 21 · 7d later | SEC filing |
| Director | Stock Option (right to buy)Grant or award | Derivative units44,964Award · no purchase price | Non-cash award | Aug 14Filed Aug 21 · 7d later | SEC filing |
| Director | Stock Option (right to buy)Grant or award | Derivative units44,964Award · no purchase price | Non-cash award | Aug 14Filed Aug 21 · 7d later | SEC filing |
| Director | Stock Option (right to buy)Grant or award | Derivative units44,964Award · no purchase price | Non-cash award | Aug 14Filed Aug 21 · 7d later | SEC filing |
This reflects the filings imported so far, not a complete trading history.
No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.
